Intra-host evolution of human immunodeficiency virus type 1 and viral fitness

New Microbiologica

Volumn 27, Issue 2 SUPPL. 1, 2004, Pages 41-44

  Clementi, M ^a   Canducci, F ^a   Bagnarelli, P ^b   Menzo, S ^b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Intra host evolution; RNA viruses; Viral fitness

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INDINAVIR; NELFINAVIR; PROTEINASE INHIBITOR; SAQUINAVIR;

CONFERENCE PAPER; DRUG SENSITIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; RNA VIRUS; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS REPLICATION;

ADAPTATION, BIOLOGICAL; AIDS VACCINES; ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; EVOLUTION, MOLECULAR; HIV INFECTIONS; HIV-1; HUMANS; SELECTION (GENETICS);

DNA VIRUSES; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 11844250555     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. BAGNARELLI, P., FIORELLI, L., VECCHI, M., MONACHETTI, A., MENZO, S., AND CLEMENTI, M. (2003). Analysis of the functional relationship between V3 loop and gp120 context with regard to human immunodeficiency virus coreceptor usage using naturally selected sequences and different viral backbones. Virology, 307, 328-340.
2. BAGNARELLI, P., MAZZOLA, F., MENZO, S., MONTRONI, M., BUTINI, L., AND CLEMENTI, M. (1999). Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution. J Virol, 73, 3764-3777.
3. BRIONES, C., DOMINGO, E., AND MOLINA-PARIS, C. (2003). Memory in retroviral quasispecies: experimental evidence and theoretical model for human immunodeficiency virus. J Mol Biol, 331, 213-229.
4. BURTON, D. (2002). Antibodies, viruses and vaccines. Nature Rev Immunol, 2, 706-713.
5. DOMINGO, E. (2000). Viruses at the edge of adaptation. Virology, 270, 251-253.
6. DOMINGO, E., BIERBRICHER, C., HOLLAND, J., AND EIGEN, M. (2001). "Quasispecies and RNA virus evolution: principles and consequences". Landes, Austin, TX.
7. DOMINGO, E., AND HOLLAND, J. (1997). RNA virus mutations and fitness for survival. Annu Rev Microbiol, 51, 151-178.
8. DOMINGO, E., HOLLAND, J., BIEBRICHER, C., AND EIGEN, M. (1995). Quasispecies: the concept and the word. In: "Molecular basis of virus evolution" (A. Gibbs, C. Calisher, and F. Garcia-Arenal, eds.). Cambridge University Press, Cambridge, 171-180.
9. DRAKE, J., AND HOLLAND, J. (1999). Mutation rates among RNA viruses. Proc Natl Acad Sci USA, 96, 390-393.
10. EIGEN, M. (1971). Self-organization of matter and evolution of biological macromulecules. Naturwissenschaften, 58, 465-523.
11. EIGEN, M. (1996). On the nature of virus quasispecies. Trends in Microbiol, 4, 216-218.
12. EIGEN, M. (2002). Error catastrophe and antiviral strategy. Proc Natl Acad Sci USA, 99, 13374-13376.
13. EIGEN, M., AND BIEBRICHER, C. (1988). Sequence space and quasispecies distribution In "RNA genetics. Volume 3." (E. Domingo, P. Ahlquist, and J. Holland, eds.). CRC Press, Boca Raiton, FL.
14. FRIEDBERG, E., WALKER, G., AND SIEDE, W. (1995). "DNA repair and mutagenesis." American Society for Microbiology, Washington, D.C.
15. LEVIN, B., LIPSITCH, M., AND BONHOEFER, S. (1999). Population biology, evolution, and infectious disease: Convergence and synthesis. Science, 283, 806-809.
16. MAMMANO, F., TROUPLIN, V., ZENNOU, V., AND CLAVEL, F. (2000). Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and the presence of drug. J Virol, 74, 8524-8532.
17. MARTINEZ-PICADO, J., SAVARA, A., SHI, L., SUTTON, L., AND D'AQUILA, R. (2000). Fitness of human immunodeficiency virus type 1 protease inhibitor-selected single mutants. Virology, 275, 318-322.
18. MENZO, S., CASTAGNA, A., MONACHETTI, A., HASSON, H., DANISE, A., CARINI, E., BAGNARELLI, P., LAZZARIN, A., AND CLEMENTI, M. (2004). Geno-phenotype patterns of HIV-1 resistance to enfuvirtide during long-term treatment. Antimicrob Agents & Chemother, in press.
19. MENZO, S., MONACHETTI, A., BALOTTA, C., CORVASCE, S., RUSCONI, S., PAOLUCCI, S., BALDANTI, F., BAGNARELLI, P., AND CLEMENTI, M. (2003). Processivity and drug-dependence of HIV-1 protease: determinants of viral fitness in variants resistant to protease inhibitors. AIDS, 17, 663-671.
20. NIJHUIS, M., DEEKS, S., AND BOUCHER, C. (2001). Implications of anti-retroviral resistance on viral fitness. Curr Opin Infect Dis, 14, 29-37.
21. NOVELLA, I., DOMINGO, E., AND HOLLAND, J. (1995). Rapid viral quasispecies evolution: Implications for vaccine and drug strategies. Mol Med Today, 1, 248-253.
22. QUINONES-MATEU, M., AND ARTS, E. (2002). Fitness of drug resistant HIV-1: methodology and clinical implications. Drug Resistance Updates, 5, 224-233.
23. REZNICK, D., AND TRAVIS, J. (1996). The empirical study of adaptation in natural populations. In "Adaptation." (Rose MR and Lauder GV, eds.), pp. 243-289. Academic Press, San Diego.
24. SATO, H., KATO, K., AND TAKEBE, Y. (1999). Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop. Virology, 257, 491-501.
25. WYATT, R., AND SODROSKI, J. (1998). The HIV-1 envelope glycoproteins: fusogens, antigens immunogens. Science, 280, 1884-1888.
26. YAMAGUCHI, Y., AND GOJOBORI, T. (1997). Evolutionary mechanisms and population dynamics of the third variable envelope region of HIV within single hosts. Proc Natl Acad Sci USA, 94, 1264-1269.